Tags

Type your tag names separated by a space and hit enter

CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Leukemia. 2008 Jun; 22(6):1207-13.L

Abstract

The presence of rare malignant stem cells supplying a hierarchy of malignant cells has recently been reported. In human acute myelogenous leukemia (AML), the leukemia stem cells (LSCs) have been phenotypically restricted within the CD34+CD38- fraction. To understand the origin of malignant cells in primary human B-precursor acute lymphocytic leukemia (B-ALL), we established a novel in vivo xenotransplantation model. Purified CD34+CD38+CD19+, CD34+CD38-CD19+ and CD34+CD38-CD19- bone marrow (BM) or peripheral blood (PB) cells from three pediatric B-ALL patients were intravenously injected into sublethally irradiated newborn NOD/SCID/IL2rgamma(null) mice. We found that both CD34+CD38+CD19+ and CD34+CD38-CD19+ cells initiate B-ALL in primary recipients, whereas the recipients of CD34+CD38-CD10-CD19- cells showed normal human hematopoietic repopulation. The extent of leukemic infiltration into the spleen, liver and kidney was similar between the recipients transplanted with CD34+CD38+CD19+ cells and those transplanted with CD34+CD38-CD19+ cells. In each of the three cases studied, transplantation of CD34+CD38+CD19+ cells resulted in the development of B-ALL in secondary recipients, demonstrating self-renewal capacity. The identification of CD34+CD38+CD19+ self-renewing B-ALL cells proposes a hierarchy of leukemia-initiating cells (LICs) distinct from that of AML. Recapitulation of patient B-ALL in NOD/SCID/IL2rgamma(null) recipients provides a powerful tool for directly studying leukemogenesis and for developing therapeutic strategies.

Authors+Show Affiliations

Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18418410

Citation

Kong, Y, et al. "CD34+CD38+CD19+ as Well as CD34+CD38-CD19+ Cells Are Leukemia-initiating Cells With Self-renewal Capacity in Human B-precursor ALL." Leukemia, vol. 22, no. 6, 2008, pp. 1207-13.
Kong Y, Yoshida S, Saito Y, et al. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia. 2008;22(6):1207-13.
Kong, Y., Yoshida, S., Saito, Y., Doi, T., Nagatoshi, Y., Fukata, M., Saito, N., Yang, S. M., Iwamoto, C., Okamura, J., Liu, K. Y., Huang, X. J., Lu, D. P., Shultz, L. D., Harada, M., & Ishikawa, F. (2008). CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia, 22(6), 1207-13. https://doi.org/10.1038/leu.2008.83
Kong Y, et al. CD34+CD38+CD19+ as Well as CD34+CD38-CD19+ Cells Are Leukemia-initiating Cells With Self-renewal Capacity in Human B-precursor ALL. Leukemia. 2008;22(6):1207-13. PubMed PMID: 18418410.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. AU - Kong,Y, AU - Yoshida,S, AU - Saito,Y, AU - Doi,T, AU - Nagatoshi,Y, AU - Fukata,M, AU - Saito,N, AU - Yang,S M, AU - Iwamoto,C, AU - Okamura,J, AU - Liu,K Y, AU - Huang,X J, AU - Lu,D P, AU - Shultz,L D, AU - Harada,M, AU - Ishikawa,F, Y1 - 2008/04/17/ PY - 2008/4/18/pubmed PY - 2008/6/27/medline PY - 2008/4/18/entrez SP - 1207 EP - 13 JF - Leukemia JO - Leukemia VL - 22 IS - 6 N2 - The presence of rare malignant stem cells supplying a hierarchy of malignant cells has recently been reported. In human acute myelogenous leukemia (AML), the leukemia stem cells (LSCs) have been phenotypically restricted within the CD34+CD38- fraction. To understand the origin of malignant cells in primary human B-precursor acute lymphocytic leukemia (B-ALL), we established a novel in vivo xenotransplantation model. Purified CD34+CD38+CD19+, CD34+CD38-CD19+ and CD34+CD38-CD19- bone marrow (BM) or peripheral blood (PB) cells from three pediatric B-ALL patients were intravenously injected into sublethally irradiated newborn NOD/SCID/IL2rgamma(null) mice. We found that both CD34+CD38+CD19+ and CD34+CD38-CD19+ cells initiate B-ALL in primary recipients, whereas the recipients of CD34+CD38-CD10-CD19- cells showed normal human hematopoietic repopulation. The extent of leukemic infiltration into the spleen, liver and kidney was similar between the recipients transplanted with CD34+CD38+CD19+ cells and those transplanted with CD34+CD38-CD19+ cells. In each of the three cases studied, transplantation of CD34+CD38+CD19+ cells resulted in the development of B-ALL in secondary recipients, demonstrating self-renewal capacity. The identification of CD34+CD38+CD19+ self-renewing B-ALL cells proposes a hierarchy of leukemia-initiating cells (LICs) distinct from that of AML. Recapitulation of patient B-ALL in NOD/SCID/IL2rgamma(null) recipients provides a powerful tool for directly studying leukemogenesis and for developing therapeutic strategies. SN - 1476-5551 UR - https://www.unboundmedicine.com/medline/citation/18418410/CD34+CD38+CD19+_as_well_as_CD34+CD38_CD19+_cells_are_leukemia_initiating_cells_with_self_renewal_capacity_in_human_B_precursor_ALL_ L2 - https://doi.org/10.1038/leu.2008.83 DB - PRIME DP - Unbound Medicine ER -